The global pain management drugs market was valued at $72.6 billion in 2023, and is projected to reach $109.6 Billion by 2033, growing at a CAGR of 4.2% from 2024 to 2033
The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027.
